CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: immunotherapy drug tested
Disease control Recruiting nowThis study tests pembrolizumab, a drug that helps the immune system fight cancer, in children aged 6 months to 18 years with advanced melanoma, solid tumors, or lymphoma that has spread, returned, or not responded to other treatments. The main goal is to see if the drug can shrin…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New drug MGD024 targets tough blood cancers in early human trial
Disease control Recruiting nowThis early-phase study tests a new drug called MGD024 in about 130 adults with certain blood cancers (like leukemia or lymphoma) that have not improved with standard treatments or have returned. The main goal is to find the safest dose and understand side effects. Participants re…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New hope for young hodgkin patients: drug combo aims to cut radiation need
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) newly diagnosed with classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs to see if it can shrink tumors faster and more completely, so fewer patients need radiation…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
Lifestyle plan aims to boost Well-Being in lymphoma survivors
Symptom relief Recruiting nowThis study tests whether a personalized healthy lifestyle plan can improve quality of life for people who have survived certain types of lymphoma (Hodgkin and some large B-cell lymphomas). Participants must be between 18 and 50 years old and have been in remission for 3 to 10 yea…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Symptom relief
Last updated Jun 09, 2026 12:08 UTC
-
Blood test may outshine scans for hodgkin relapse risk
Knowledge-focused Recruiting nowThis study is looking at whether a blood test that detects tumor DNA can help doctors better predict if Hodgkin lymphoma will come back in children and young adults. About 400 participants under 25 will give blood samples before, during, and after treatment. The goal is to see if…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
New study aims to predict hodgkin lymphoma relapse before it happens
Knowledge-focused Recruiting nowThis observational study looks at 755 people with classical Hodgkin lymphoma to find better ways to predict if the cancer will come back or resist treatment. Researchers will analyze tumor genetics and PET scan images to identify high-risk patterns. The goal is to personalize tre…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC